TLR4 and exocrine pancreatic carcinoma: How to cite this article: Prakash, H. et al. CD14/TLR4 priming potentially recalibrates and exerts anti-tumor efficacy in tumor associated macrophages in a mouse model of pancreatic carcinoma.